A detailed history of William Von Mueffling (Cantillon Capital Management LLC) transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Cantillon Capital Management LLC holds 864,714 shares of TMO stock, worth $467 Million. This represents 3.22% of its overall portfolio holdings.

Number of Shares
864,714
Previous 882,017 1.96%
Holding current value
$467 Million
Previous $468 Million 7.35%
% of portfolio
3.22%
Previous 3.17%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$528.82 - $599.43 $9.15 Million - $10.4 Million
-17,303 Reduced 1.96%
864,714 $503 Million
Q4 2023

Feb 07, 2024

SELL
$431.41 - $532.94 $9.38 Million - $11.6 Million
-21,746 Reduced 2.41%
882,017 $468 Million
Q3 2023

Nov 06, 2023

SELL
$498.29 - $574.41 $1.72 Million - $1.98 Million
-3,451 Reduced 0.38%
903,763 $457 Million
Q2 2023

Aug 09, 2023

BUY
$508.46 - $591.13 $44.3 Million - $51.5 Million
87,092 Added 10.62%
907,214 $473 Million
Q1 2023

May 04, 2023

SELL
$535.0 - $604.82 $7.93 Million - $8.97 Million
-14,827 Reduced 1.78%
820,122 $473 Million
Q4 2022

Feb 06, 2023

SELL
$484.71 - $571.37 $7.99 Million - $9.42 Million
-16,490 Reduced 1.94%
834,949 $460 Million
Q3 2022

Nov 03, 2022

SELL
$507.19 - $604.49 $3.43 Million - $4.09 Million
-6,767 Reduced 0.79%
851,439 $432 Million
Q2 2022

Aug 03, 2022

SELL
$500.9 - $612.21 $2.35 Million - $2.87 Million
-4,695 Reduced 0.54%
858,206 $466 Million
Q1 2022

May 03, 2022

BUY
$524.0 - $644.92 $12.9 Million - $15.9 Million
24,611 Added 2.94%
862,901 $510 Million
Q4 2021

Jan 27, 2022

SELL
$569.0 - $667.24 $35.8 Million - $42 Million
-62,921 Reduced 6.98%
838,290 $559 Million
Q3 2021

Oct 26, 2021

SELL
$509.53 - $609.78 $7.88 Million - $9.43 Million
-15,459 Reduced 1.69%
901,211 $515 Million
Q2 2021

Jul 27, 2021

SELL
$441.0 - $508.24 $5.62 Million - $6.47 Million
-12,734 Reduced 1.37%
916,670 $462 Million
Q1 2021

May 03, 2021

SELL
$439.85 - $518.83 $15.3 Million - $18.1 Million
-34,796 Reduced 3.61%
929,404 $424 Million
Q4 2020

Feb 03, 2021

SELL
$435.06 - $527.66 $2.08 Million - $2.52 Million
-4,781 Reduced 0.49%
964,200 $449 Million
Q3 2020

Oct 30, 2020

SELL
$359.77 - $441.52 $4.27 Million - $5.24 Million
-11,867 Reduced 1.21%
968,981 $428 Million
Q2 2020

Jul 31, 2020

BUY
$275.2 - $362.34 $2.84 Million - $3.74 Million
10,323 Added 1.06%
980,848 $355 Million
Q1 2020

Apr 30, 2020

SELL
$255.3 - $340.05 $320,656 - $427,102
-1,256 Reduced 0.13%
970,525 $275 Million
Q4 2019

Feb 07, 2020

SELL
$271.93 - $328.04 $5.73 Million - $6.92 Million
-21,083 Reduced 2.12%
971,781 $316 Million
Q3 2019

Nov 04, 2019

SELL
$268.46 - $305.43 $2.18 Million - $2.48 Million
-8,117 Reduced 0.81%
992,864 $289 Million
Q2 2019

Jul 26, 2019

SELL
$257.51 - $295.55 $5.35 Million - $6.14 Million
-20,764 Reduced 2.03%
1,000,981 $294 Million
Q1 2019

May 01, 2019

SELL
$212.17 - $273.72 $675,761 - $871,798
-3,185 Reduced 0.31%
1,021,745 $280 Million
Q4 2018

Feb 05, 2019

BUY
$208.47 - $251.98 $102 Million - $123 Million
489,081 Added 91.27%
1,024,930 $229 Million
Q3 2018

Nov 09, 2018

BUY
$205.57 - $244.32 $110 Million - $131 Million
535,849 New
535,849 $131 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $212B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track William Von Mueffling's Portfolio

Track William Von Mueffling Portfolio

Follow William Von Mueffling (Cantillon Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantillon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cantillon Capital Management LLC and William Von Mueffling with notifications on news.